Papulopustular Rosacea Documentation Guidelines

Essential Clinical Features to Document

The British Journal of Dermatology recommends documenting the number and extent of inflammatory papules and pustules on the face, along with the intensity and extent of any background erythema, associated symptoms, and presence of ocular manifestations 1, 2, 3
Document the specific number of papules and pustules present, as recommended by the British Journal of Dermatology 3
Record which facial areas are affected and the percentage of centrofacial distribution, as suggested by the British Journal of Dermatology 3
Note the degree of redness associated with individual lesions, as recommended by the British Journal of Dermatology 3
Grade the severity of non-transient facial redness, as suggested by the British Journal of Dermatology 3
Document the area of facial involvement with persistent redness, as recommended by the British Journal of Dermatology 3
Confirm the central facial distribution, which is essential for diagnosis, according to the British Journal of Dermatology 1, 2
Record vessel size and extent of involvement if telangiectasia is present, as recommended by the British Journal of Dermatology 3
Document frequency, duration, intensity, area involved, and triggering factors of flushing episodes, as suggested by the British Journal of Dermatology 3
Note presence and severity of burning sensation, stinging, dry sensation, or edema, as recommended by the British Journal of Dermatology 3

Document blepharitis, meibomian gland dysfunction, or lid margin telangiectasia, as recommended by the British Journal of Dermatology 3
Note conjunctival injection or blepharoconjunctivitis, as suggested by the British Journal of Dermatology 3

Use a 5-point categorical scale for each feature independently, as recommended by the British Journal of Dermatology 3
The scale should include: Clear/none, Almost clear/minimal, Mild, Moderate, Severe, as suggested by the British Journal of Dermatology 3

Document how the condition affects the patient's daily life and emotional well-being, as recommended by the British Journal of Dermatology 1, 2
Note involvement of highly visible facial areas, as suggested by the Annals of Oncology 4
Record how burning, stinging, or pain affects function, as recommended by the Annals of Oncology 4

Photographs are essential for tracking phymatous changes and treatment response, as recommended by the British Journal of Dermatology 3
Document changes over time to assess treatment efficacy, as suggested by the British Journal of Dermatology 3

Record changes in each phenotypic feature independently at 4-6 week intervals, including reduction in lesion count, decrease in erythema severity, frequency of flare episodes, patient-reported improvement in visible and non-visible features, and impact on quality of life, as recommended by the British Journal of Dermatology 3

The presence of persistent centrofacial erythema with telangiectasia and ectasia, exacerbated by exercise and outdoor exposure, accompanied by a stinging sensation, is diagnostic of rosacea, according to the British Journal of Dermatology 5, 6
Persistent centrofacial erythema with periodic intensification by trigger factors meets the minimum diagnostic criteria for rosacea, as stated by the British Journal of Dermatology 5, 7, 8
Telangiectasia and ectasia on the cheeks, nose, and ears represent major features of rosacea, though not independently diagnostic, according to the British Journal of Dermatology 5, 7
A stinging sensation is a recognized minor feature of rosacea, as noted by the British Journal of Dermatology 5, 7
Centrofacial distribution is essential for rosacea diagnosis, as stated by the British Journal of Dermatology 5, 7

Evaluate for ocular rosacea, as it commonly accompanies cutaneous disease and can lead to sight-threatening complications if untreated, according to Ophthalmology and the British Journal of Dermatology 7, 9
Ask about eye symptoms, such as burning, stinging, dryness, foreign body sensation, or recurrent styes, and examine for blepharitis, meibomian gland dysfunction, conjunctival injection, or corneal involvement, as recommended by Ophthalmology 9

The British Journal of Dermatology recommends photoprotection using broad-spectrum sunscreen and wide-brimmed hats, as UV radiation activates inflammatory pathways 6
The American Academy of Dermatology is not mentioned in this article, however the British Journal of Dermatology suggests that treatment goals include reducing erythema intensity, decreasing flush frequency, improving patient-reported symptoms, and enhancing quality of life 7

Assess treatment response at 4-6 weeks and evaluate each phenotypic feature independently, rather than using subtype classification, as stated by the British Journal of Dermatology 5, 7

The American Academy of Ophthalmology recommends evaluating for ocular involvement immediately in patients with rosacea, as ocular rosacea can lead to sight-threatening complications if untreated, and patients may present with symptoms such as burning, stinging, dryness, foreign body sensation, or recurrent styes 10
The American Academy of Ophthalmology notes that children with ocular rosacea may present with corneal involvement and potential for visual impairment, including corneal melting/perforation, highlighting the importance of prompt diagnosis and treatment 11

The American Academy of Ophthalmology suggests examining patients with rosacea for blepharitis, meibomian gland dysfunction, conjunctival injection, or corneal involvement, as these are common manifestations of ocular rosacea 10